Global Biological Excipient Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
LPI (LP Information)' newest research report, the “Biological Excipient Industry Forecast” looks at past sales and reviews total world Biological Excipient sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Excipient sales for 2023 through 2029. With Biological Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Excipient industry.
This Insight Report provides a comprehensive analysis of the global Biological Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biological Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Excipient and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Excipient.
The global Biological Excipient market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biological Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biological Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biological Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biological Excipient players cover Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, Roquette Fr?res, Signet Chemical Corporation Pvt. Ltd., The Archer Daniels Midland Company and The Dow Chemical Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Excipient market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Biological Excipient market?
What factors are driving Biological Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biological Excipient market opportunities vary by end market size?
How does Biological Excipient break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
LPI (LP Information)' newest research report, the “Biological Excipient Industry Forecast” looks at past sales and reviews total world Biological Excipient sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Excipient sales for 2023 through 2029. With Biological Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Excipient industry.
This Insight Report provides a comprehensive analysis of the global Biological Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biological Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Excipient and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Excipient.
The global Biological Excipient market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biological Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biological Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biological Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biological Excipient players cover Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, Roquette Fr?res, Signet Chemical Corporation Pvt. Ltd., The Archer Daniels Midland Company and The Dow Chemical Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Excipient market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- Topical
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ashland Inc.
- BASF Corporation
- Colorcon Inc.
- Evonik Industries
- FMC Corporation
- Roquette Fr?res
- Signet Chemical Corporation Pvt. Ltd.
- The Archer Daniels Midland Company
- The Dow Chemical Company
- Wacker Chemie AG.
- Merck KGaA
- Colorcon
- Associated British Foods plc
- Signet Excipients Pvt. Ltd (IMCD)
- Sigachi Industries Limited
- Spectrum Chemical Manufacturing Corp.
- IMCD
- Clariant
What is the 10-year outlook for the global Biological Excipient market?
What factors are driving Biological Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biological Excipient market opportunities vary by end market size?
How does Biological Excipient break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biological Excipient Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biological Excipient by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biological Excipient by Country/Region, 2018, 2022 & 2029
2.2 Biological Excipient Segment by Type
2.2.1 Oral
2.2.2 Topical
2.3 Biological Excipient Sales by Type
2.3.1 Global Biological Excipient Sales Market Share by Type (2018-2023)
2.3.2 Global Biological Excipient Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biological Excipient Sale Price by Type (2018-2023)
2.4 Biological Excipient Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Biological Excipient Sales by Application
2.5.1 Global Biological Excipient Sale Market Share by Application (2018-2023)
2.5.2 Global Biological Excipient Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biological Excipient Sale Price by Application (2018-2023)
3 GLOBAL BIOLOGICAL EXCIPIENT BY COMPANY
3.1 Global Biological Excipient Breakdown Data by Company
3.1.1 Global Biological Excipient Annual Sales by Company (2018-2023)
3.1.2 Global Biological Excipient Sales Market Share by Company (2018-2023)
3.2 Global Biological Excipient Annual Revenue by Company (2018-2023)
3.2.1 Global Biological Excipient Revenue by Company (2018-2023)
3.2.2 Global Biological Excipient Revenue Market Share by Company (2018-2023)
3.3 Global Biological Excipient Sale Price by Company
3.4 Key Manufacturers Biological Excipient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biological Excipient Product Location Distribution
3.4.2 Players Biological Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGICAL EXCIPIENT BY GEOGRAPHIC REGION
4.1 World Historic Biological Excipient Market Size by Geographic Region (2018-2023)
4.1.1 Global Biological Excipient Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biological Excipient Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biological Excipient Market Size by Country/Region (2018-2023)
4.2.1 Global Biological Excipient Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biological Excipient Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biological Excipient Sales Growth
4.4 APAC Biological Excipient Sales Growth
4.5 Europe Biological Excipient Sales Growth
4.6 Middle East & Africa Biological Excipient Sales Growth
5 AMERICAS
5.1 Americas Biological Excipient Sales by Country
5.1.1 Americas Biological Excipient Sales by Country (2018-2023)
5.1.2 Americas Biological Excipient Revenue by Country (2018-2023)
5.2 Americas Biological Excipient Sales by Type
5.3 Americas Biological Excipient Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biological Excipient Sales by Region
6.1.1 APAC Biological Excipient Sales by Region (2018-2023)
6.1.2 APAC Biological Excipient Revenue by Region (2018-2023)
6.2 APAC Biological Excipient Sales by Type
6.3 APAC Biological Excipient Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biological Excipient by Country
7.1.1 Europe Biological Excipient Sales by Country (2018-2023)
7.1.2 Europe Biological Excipient Revenue by Country (2018-2023)
7.2 Europe Biological Excipient Sales by Type
7.3 Europe Biological Excipient Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biological Excipient by Country
8.1.1 Middle East & Africa Biological Excipient Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biological Excipient Revenue by Country (2018-2023)
8.2 Middle East & Africa Biological Excipient Sales by Type
8.3 Middle East & Africa Biological Excipient Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biological Excipient
10.3 Manufacturing Process Analysis of Biological Excipient
10.4 Industry Chain Structure of Biological Excipient
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biological Excipient Distributors
11.3 Biological Excipient Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICAL EXCIPIENT BY GEOGRAPHIC REGION
12.1 Global Biological Excipient Market Size Forecast by Region
12.1.1 Global Biological Excipient Forecast by Region (2024-2029)
12.1.2 Global Biological Excipient Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biological Excipient Forecast by Type
12.7 Global Biological Excipient Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ashland Inc.
13.1.1 Ashland Inc. Company Information
13.1.2 Ashland Inc. Biological Excipient Product Portfolios and Specifications
13.1.3 Ashland Inc. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ashland Inc. Main Business Overview
13.1.5 Ashland Inc. Latest Developments
13.2 BASF Corporation
13.2.1 BASF Corporation Company Information
13.2.2 BASF Corporation Biological Excipient Product Portfolios and Specifications
13.2.3 BASF Corporation Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BASF Corporation Main Business Overview
13.2.5 BASF Corporation Latest Developments
13.3 Colorcon Inc.
13.3.1 Colorcon Inc. Company Information
13.3.2 Colorcon Inc. Biological Excipient Product Portfolios and Specifications
13.3.3 Colorcon Inc. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Colorcon Inc. Main Business Overview
13.3.5 Colorcon Inc. Latest Developments
13.4 Evonik Industries
13.4.1 Evonik Industries Company Information
13.4.2 Evonik Industries Biological Excipient Product Portfolios and Specifications
13.4.3 Evonik Industries Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Evonik Industries Main Business Overview
13.4.5 Evonik Industries Latest Developments
13.5 FMC Corporation
13.5.1 FMC Corporation Company Information
13.5.2 FMC Corporation Biological Excipient Product Portfolios and Specifications
13.5.3 FMC Corporation Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 FMC Corporation Main Business Overview
13.5.5 FMC Corporation Latest Developments
13.6 Roquette Fr?res
13.6.1 Roquette Fr?res Company Information
13.6.2 Roquette Fr?res Biological Excipient Product Portfolios and Specifications
13.6.3 Roquette Fr?res Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roquette Fr?res Main Business Overview
13.6.5 Roquette Fr?res Latest Developments
13.7 Signet Chemical Corporation Pvt. Ltd.
13.7.1 Signet Chemical Corporation Pvt. Ltd. Company Information
13.7.2 Signet Chemical Corporation Pvt. Ltd. Biological Excipient Product Portfolios and Specifications
13.7.3 Signet Chemical Corporation Pvt. Ltd. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Signet Chemical Corporation Pvt. Ltd. Main Business Overview
13.7.5 Signet Chemical Corporation Pvt. Ltd. Latest Developments
13.8 The Archer Daniels Midland Company
13.8.1 The Archer Daniels Midland Company Company Information
13.8.2 The Archer Daniels Midland Company Biological Excipient Product Portfolios and Specifications
13.8.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 The Archer Daniels Midland Company Main Business Overview
13.8.5 The Archer Daniels Midland Company Latest Developments
13.9 The Dow Chemical Company
13.9.1 The Dow Chemical Company Company Information
13.9.2 The Dow Chemical Company Biological Excipient Product Portfolios and Specifications
13.9.3 The Dow Chemical Company Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 The Dow Chemical Company Main Business Overview
13.9.5 The Dow Chemical Company Latest Developments
13.10 Wacker Chemie AG.
13.10.1 Wacker Chemie AG. Company Information
13.10.2 Wacker Chemie AG. Biological Excipient Product Portfolios and Specifications
13.10.3 Wacker Chemie AG. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wacker Chemie AG. Main Business Overview
13.10.5 Wacker Chemie AG. Latest Developments
13.11 Merck KGaA
13.11.1 Merck KGaA Company Information
13.11.2 Merck KGaA Biological Excipient Product Portfolios and Specifications
13.11.3 Merck KGaA Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Merck KGaA Main Business Overview
13.11.5 Merck KGaA Latest Developments
13.12 Colorcon
13.12.1 Colorcon Company Information
13.12.2 Colorcon Biological Excipient Product Portfolios and Specifications
13.12.3 Colorcon Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Colorcon Main Business Overview
13.12.5 Colorcon Latest Developments
13.13 Associated British Foods plc
13.13.1 Associated British Foods plc Company Information
13.13.2 Associated British Foods plc Biological Excipient Product Portfolios and Specifications
13.13.3 Associated British Foods plc Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Associated British Foods plc Main Business Overview
13.13.5 Associated British Foods plc Latest Developments
13.14 Signet Excipients Pvt. Ltd (IMCD)
13.14.1 Signet Excipients Pvt. Ltd (IMCD) Company Information
13.14.2 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolios and Specifications
13.14.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Signet Excipients Pvt. Ltd (IMCD) Main Business Overview
13.14.5 Signet Excipients Pvt. Ltd (IMCD) Latest Developments
13.15 Sigachi Industries Limited
13.15.1 Sigachi Industries Limited Company Information
13.15.2 Sigachi Industries Limited Biological Excipient Product Portfolios and Specifications
13.15.3 Sigachi Industries Limited Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sigachi Industries Limited Main Business Overview
13.15.5 Sigachi Industries Limited Latest Developments
13.16 Spectrum Chemical Manufacturing Corp.
13.16.1 Spectrum Chemical Manufacturing Corp. Company Information
13.16.2 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolios and Specifications
13.16.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Spectrum Chemical Manufacturing Corp. Main Business Overview
13.16.5 Spectrum Chemical Manufacturing Corp. Latest Developments
13.17 IMCD
13.17.1 IMCD Company Information
13.17.2 IMCD Biological Excipient Product Portfolios and Specifications
13.17.3 IMCD Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 IMCD Main Business Overview
13.17.5 IMCD Latest Developments
13.18 Clariant
13.18.1 Clariant Company Information
13.18.2 Clariant Biological Excipient Product Portfolios and Specifications
13.18.3 Clariant Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Clariant Main Business Overview
13.18.5 Clariant Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biological Excipient Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biological Excipient by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biological Excipient by Country/Region, 2018, 2022 & 2029
2.2 Biological Excipient Segment by Type
2.2.1 Oral
2.2.2 Topical
2.3 Biological Excipient Sales by Type
2.3.1 Global Biological Excipient Sales Market Share by Type (2018-2023)
2.3.2 Global Biological Excipient Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biological Excipient Sale Price by Type (2018-2023)
2.4 Biological Excipient Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Biological Excipient Sales by Application
2.5.1 Global Biological Excipient Sale Market Share by Application (2018-2023)
2.5.2 Global Biological Excipient Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biological Excipient Sale Price by Application (2018-2023)
3 GLOBAL BIOLOGICAL EXCIPIENT BY COMPANY
3.1 Global Biological Excipient Breakdown Data by Company
3.1.1 Global Biological Excipient Annual Sales by Company (2018-2023)
3.1.2 Global Biological Excipient Sales Market Share by Company (2018-2023)
3.2 Global Biological Excipient Annual Revenue by Company (2018-2023)
3.2.1 Global Biological Excipient Revenue by Company (2018-2023)
3.2.2 Global Biological Excipient Revenue Market Share by Company (2018-2023)
3.3 Global Biological Excipient Sale Price by Company
3.4 Key Manufacturers Biological Excipient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biological Excipient Product Location Distribution
3.4.2 Players Biological Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGICAL EXCIPIENT BY GEOGRAPHIC REGION
4.1 World Historic Biological Excipient Market Size by Geographic Region (2018-2023)
4.1.1 Global Biological Excipient Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biological Excipient Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biological Excipient Market Size by Country/Region (2018-2023)
4.2.1 Global Biological Excipient Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biological Excipient Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biological Excipient Sales Growth
4.4 APAC Biological Excipient Sales Growth
4.5 Europe Biological Excipient Sales Growth
4.6 Middle East & Africa Biological Excipient Sales Growth
5 AMERICAS
5.1 Americas Biological Excipient Sales by Country
5.1.1 Americas Biological Excipient Sales by Country (2018-2023)
5.1.2 Americas Biological Excipient Revenue by Country (2018-2023)
5.2 Americas Biological Excipient Sales by Type
5.3 Americas Biological Excipient Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biological Excipient Sales by Region
6.1.1 APAC Biological Excipient Sales by Region (2018-2023)
6.1.2 APAC Biological Excipient Revenue by Region (2018-2023)
6.2 APAC Biological Excipient Sales by Type
6.3 APAC Biological Excipient Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biological Excipient by Country
7.1.1 Europe Biological Excipient Sales by Country (2018-2023)
7.1.2 Europe Biological Excipient Revenue by Country (2018-2023)
7.2 Europe Biological Excipient Sales by Type
7.3 Europe Biological Excipient Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biological Excipient by Country
8.1.1 Middle East & Africa Biological Excipient Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biological Excipient Revenue by Country (2018-2023)
8.2 Middle East & Africa Biological Excipient Sales by Type
8.3 Middle East & Africa Biological Excipient Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biological Excipient
10.3 Manufacturing Process Analysis of Biological Excipient
10.4 Industry Chain Structure of Biological Excipient
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biological Excipient Distributors
11.3 Biological Excipient Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICAL EXCIPIENT BY GEOGRAPHIC REGION
12.1 Global Biological Excipient Market Size Forecast by Region
12.1.1 Global Biological Excipient Forecast by Region (2024-2029)
12.1.2 Global Biological Excipient Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biological Excipient Forecast by Type
12.7 Global Biological Excipient Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ashland Inc.
13.1.1 Ashland Inc. Company Information
13.1.2 Ashland Inc. Biological Excipient Product Portfolios and Specifications
13.1.3 Ashland Inc. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ashland Inc. Main Business Overview
13.1.5 Ashland Inc. Latest Developments
13.2 BASF Corporation
13.2.1 BASF Corporation Company Information
13.2.2 BASF Corporation Biological Excipient Product Portfolios and Specifications
13.2.3 BASF Corporation Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BASF Corporation Main Business Overview
13.2.5 BASF Corporation Latest Developments
13.3 Colorcon Inc.
13.3.1 Colorcon Inc. Company Information
13.3.2 Colorcon Inc. Biological Excipient Product Portfolios and Specifications
13.3.3 Colorcon Inc. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Colorcon Inc. Main Business Overview
13.3.5 Colorcon Inc. Latest Developments
13.4 Evonik Industries
13.4.1 Evonik Industries Company Information
13.4.2 Evonik Industries Biological Excipient Product Portfolios and Specifications
13.4.3 Evonik Industries Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Evonik Industries Main Business Overview
13.4.5 Evonik Industries Latest Developments
13.5 FMC Corporation
13.5.1 FMC Corporation Company Information
13.5.2 FMC Corporation Biological Excipient Product Portfolios and Specifications
13.5.3 FMC Corporation Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 FMC Corporation Main Business Overview
13.5.5 FMC Corporation Latest Developments
13.6 Roquette Fr?res
13.6.1 Roquette Fr?res Company Information
13.6.2 Roquette Fr?res Biological Excipient Product Portfolios and Specifications
13.6.3 Roquette Fr?res Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roquette Fr?res Main Business Overview
13.6.5 Roquette Fr?res Latest Developments
13.7 Signet Chemical Corporation Pvt. Ltd.
13.7.1 Signet Chemical Corporation Pvt. Ltd. Company Information
13.7.2 Signet Chemical Corporation Pvt. Ltd. Biological Excipient Product Portfolios and Specifications
13.7.3 Signet Chemical Corporation Pvt. Ltd. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Signet Chemical Corporation Pvt. Ltd. Main Business Overview
13.7.5 Signet Chemical Corporation Pvt. Ltd. Latest Developments
13.8 The Archer Daniels Midland Company
13.8.1 The Archer Daniels Midland Company Company Information
13.8.2 The Archer Daniels Midland Company Biological Excipient Product Portfolios and Specifications
13.8.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 The Archer Daniels Midland Company Main Business Overview
13.8.5 The Archer Daniels Midland Company Latest Developments
13.9 The Dow Chemical Company
13.9.1 The Dow Chemical Company Company Information
13.9.2 The Dow Chemical Company Biological Excipient Product Portfolios and Specifications
13.9.3 The Dow Chemical Company Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 The Dow Chemical Company Main Business Overview
13.9.5 The Dow Chemical Company Latest Developments
13.10 Wacker Chemie AG.
13.10.1 Wacker Chemie AG. Company Information
13.10.2 Wacker Chemie AG. Biological Excipient Product Portfolios and Specifications
13.10.3 Wacker Chemie AG. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wacker Chemie AG. Main Business Overview
13.10.5 Wacker Chemie AG. Latest Developments
13.11 Merck KGaA
13.11.1 Merck KGaA Company Information
13.11.2 Merck KGaA Biological Excipient Product Portfolios and Specifications
13.11.3 Merck KGaA Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Merck KGaA Main Business Overview
13.11.5 Merck KGaA Latest Developments
13.12 Colorcon
13.12.1 Colorcon Company Information
13.12.2 Colorcon Biological Excipient Product Portfolios and Specifications
13.12.3 Colorcon Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Colorcon Main Business Overview
13.12.5 Colorcon Latest Developments
13.13 Associated British Foods plc
13.13.1 Associated British Foods plc Company Information
13.13.2 Associated British Foods plc Biological Excipient Product Portfolios and Specifications
13.13.3 Associated British Foods plc Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Associated British Foods plc Main Business Overview
13.13.5 Associated British Foods plc Latest Developments
13.14 Signet Excipients Pvt. Ltd (IMCD)
13.14.1 Signet Excipients Pvt. Ltd (IMCD) Company Information
13.14.2 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolios and Specifications
13.14.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Signet Excipients Pvt. Ltd (IMCD) Main Business Overview
13.14.5 Signet Excipients Pvt. Ltd (IMCD) Latest Developments
13.15 Sigachi Industries Limited
13.15.1 Sigachi Industries Limited Company Information
13.15.2 Sigachi Industries Limited Biological Excipient Product Portfolios and Specifications
13.15.3 Sigachi Industries Limited Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sigachi Industries Limited Main Business Overview
13.15.5 Sigachi Industries Limited Latest Developments
13.16 Spectrum Chemical Manufacturing Corp.
13.16.1 Spectrum Chemical Manufacturing Corp. Company Information
13.16.2 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolios and Specifications
13.16.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Spectrum Chemical Manufacturing Corp. Main Business Overview
13.16.5 Spectrum Chemical Manufacturing Corp. Latest Developments
13.17 IMCD
13.17.1 IMCD Company Information
13.17.2 IMCD Biological Excipient Product Portfolios and Specifications
13.17.3 IMCD Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 IMCD Main Business Overview
13.17.5 IMCD Latest Developments
13.18 Clariant
13.18.1 Clariant Company Information
13.18.2 Clariant Biological Excipient Product Portfolios and Specifications
13.18.3 Clariant Biological Excipient Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Clariant Main Business Overview
13.18.5 Clariant Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biological Excipient Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biological Excipient Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Topical
Table 5. Global Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 6. Global Biological Excipient Sales Market Share by Type (2018-2023)
Table 7. Global Biological Excipient Revenue by Type (2018-2023) & ($ million)
Table 8. Global Biological Excipient Revenue Market Share by Type (2018-2023)
Table 9. Global Biological Excipient Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 11. Global Biological Excipient Sales Market Share by Application (2018-2023)
Table 12. Global Biological Excipient Revenue by Application (2018-2023)
Table 13. Global Biological Excipient Revenue Market Share by Application (2018-2023)
Table 14. Global Biological Excipient Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Biological Excipient Sales by Company (2018-2023) & (K Units)
Table 16. Global Biological Excipient Sales Market Share by Company (2018-2023)
Table 17. Global Biological Excipient Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Biological Excipient Revenue Market Share by Company (2018-2023)
Table 19. Global Biological Excipient Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Biological Excipient Producing Area Distribution and Sales Area
Table 21. Players Biological Excipient Products Offered
Table 22. Biological Excipient Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biological Excipient Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Biological Excipient Sales Market Share Geographic Region (2018-2023)
Table 27. Global Biological Excipient Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Biological Excipient Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Biological Excipient Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Biological Excipient Sales Market Share by Country/Region (2018-2023)
Table 31. Global Biological Excipient Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Biological Excipient Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Biological Excipient Sales by Country (2018-2023) & (K Units)
Table 34. Americas Biological Excipient Sales Market Share by Country (2018-2023)
Table 35. Americas Biological Excipient Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Biological Excipient Revenue Market Share by Country (2018-2023)
Table 37. Americas Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 38. Americas Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 39. APAC Biological Excipient Sales by Region (2018-2023) & (K Units)
Table 40. APAC Biological Excipient Sales Market Share by Region (2018-2023)
Table 41. APAC Biological Excipient Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Biological Excipient Revenue Market Share by Region (2018-2023)
Table 43. APAC Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 44. APAC Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 45. Europe Biological Excipient Sales by Country (2018-2023) & (K Units)
Table 46. Europe Biological Excipient Sales Market Share by Country (2018-2023)
Table 47. Europe Biological Excipient Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Biological Excipient Revenue Market Share by Country (2018-2023)
Table 49. Europe Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 50. Europe Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Biological Excipient Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Biological Excipient Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Biological Excipient Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Biological Excipient Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Biological Excipient
Table 58. Key Market Challenges & Risks of Biological Excipient
Table 59. Key Industry Trends of Biological Excipient
Table 60. Biological Excipient Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Biological Excipient Distributors List
Table 63. Biological Excipient Customer List
Table 64. Global Biological Excipient Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Biological Excipient Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Biological Excipient Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Biological Excipient Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Biological Excipient Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Biological Excipient Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Biological Excipient Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Biological Excipient Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Biological Excipient Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Biological Excipient Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Biological Excipient Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Biological Excipient Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Biological Excipient Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Biological Excipient Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ashland Inc. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 79. Ashland Inc. Biological Excipient Product Portfolios and Specifications
Table 80. Ashland Inc. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Ashland Inc. Main Business
Table 82. Ashland Inc. Latest Developments
Table 83. BASF Corporation Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 84. BASF Corporation Biological Excipient Product Portfolios and Specifications
Table 85. BASF Corporation Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BASF Corporation Main Business
Table 87. BASF Corporation Latest Developments
Table 88. Colorcon Inc. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 89. Colorcon Inc. Biological Excipient Product Portfolios and Specifications
Table 90. Colorcon Inc. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Colorcon Inc. Main Business
Table 92. Colorcon Inc. Latest Developments
Table 93. Evonik Industries Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 94. Evonik Industries Biological Excipient Product Portfolios and Specifications
Table 95. Evonik Industries Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Evonik Industries Main Business
Table 97. Evonik Industries Latest Developments
Table 98. FMC Corporation Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 99. FMC Corporation Biological Excipient Product Portfolios and Specifications
Table 100. FMC Corporation Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. FMC Corporation Main Business
Table 102. FMC Corporation Latest Developments
Table 103. Roquette Fr?res Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 104. Roquette Fr?res Biological Excipient Product Portfolios and Specifications
Table 105. Roquette Fr?res Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Roquette Fr?res Main Business
Table 107. Roquette Fr?res Latest Developments
Table 108. Signet Chemical Corporation Pvt. Ltd. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 109. Signet Chemical Corporation Pvt. Ltd. Biological Excipient Product Portfolios and Specifications
Table 110. Signet Chemical Corporation Pvt. Ltd. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Signet Chemical Corporation Pvt. Ltd. Main Business
Table 112. Signet Chemical Corporation Pvt. Ltd. Latest Developments
Table 113. The Archer Daniels Midland Company Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 114. The Archer Daniels Midland Company Biological Excipient Product Portfolios and Specifications
Table 115. The Archer Daniels Midland Company Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. The Archer Daniels Midland Company Main Business
Table 117. The Archer Daniels Midland Company Latest Developments
Table 118. The Dow Chemical Company Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 119. The Dow Chemical Company Biological Excipient Product Portfolios and Specifications
Table 120. The Dow Chemical Company Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. The Dow Chemical Company Main Business
Table 122. The Dow Chemical Company Latest Developments
Table 123. Wacker Chemie AG. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 124. Wacker Chemie AG. Biological Excipient Product Portfolios and Specifications
Table 125. Wacker Chemie AG. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Wacker Chemie AG. Main Business
Table 127. Wacker Chemie AG. Latest Developments
Table 128. Merck KGaA Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 129. Merck KGaA Biological Excipient Product Portfolios and Specifications
Table 130. Merck KGaA Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Merck KGaA Main Business
Table 132. Merck KGaA Latest Developments
Table 133. Colorcon Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 134. Colorcon Biological Excipient Product Portfolios and Specifications
Table 135. Colorcon Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Colorcon Main Business
Table 137. Colorcon Latest Developments
Table 138. Associated British Foods plc Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 139. Associated British Foods plc Biological Excipient Product Portfolios and Specifications
Table 140. Associated British Foods plc Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Associated British Foods plc Main Business
Table 142. Associated British Foods plc Latest Developments
Table 143. Signet Excipients Pvt. Ltd (IMCD) Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 144. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolios and Specifications
Table 145. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Signet Excipients Pvt. Ltd (IMCD) Main Business
Table 147. Signet Excipients Pvt. Ltd (IMCD) Latest Developments
Table 148. Sigachi Industries Limited Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 149. Sigachi Industries Limited Biological Excipient Product Portfolios and Specifications
Table 150. Sigachi Industries Limited Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Sigachi Industries Limited Main Business
Table 152. Sigachi Industries Limited Latest Developments
Table 153. Spectrum Chemical Manufacturing Corp. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 154. Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolios and Specifications
Table 155. Spectrum Chemical Manufacturing Corp. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Spectrum Chemical Manufacturing Corp. Main Business
Table 157. Spectrum Chemical Manufacturing Corp. Latest Developments
Table 158. IMCD Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 159. IMCD Biological Excipient Product Portfolios and Specifications
Table 160. IMCD Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. IMCD Main Business
Table 162. IMCD Latest Developments
Table 163. Clariant Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 164. Clariant Biological Excipient Product Portfolios and Specifications
Table 165. Clariant Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Clariant Main Business
Table 167. Clariant Latest Developments
Table 1. Biological Excipient Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biological Excipient Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Topical
Table 5. Global Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 6. Global Biological Excipient Sales Market Share by Type (2018-2023)
Table 7. Global Biological Excipient Revenue by Type (2018-2023) & ($ million)
Table 8. Global Biological Excipient Revenue Market Share by Type (2018-2023)
Table 9. Global Biological Excipient Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 11. Global Biological Excipient Sales Market Share by Application (2018-2023)
Table 12. Global Biological Excipient Revenue by Application (2018-2023)
Table 13. Global Biological Excipient Revenue Market Share by Application (2018-2023)
Table 14. Global Biological Excipient Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Biological Excipient Sales by Company (2018-2023) & (K Units)
Table 16. Global Biological Excipient Sales Market Share by Company (2018-2023)
Table 17. Global Biological Excipient Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Biological Excipient Revenue Market Share by Company (2018-2023)
Table 19. Global Biological Excipient Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Biological Excipient Producing Area Distribution and Sales Area
Table 21. Players Biological Excipient Products Offered
Table 22. Biological Excipient Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biological Excipient Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Biological Excipient Sales Market Share Geographic Region (2018-2023)
Table 27. Global Biological Excipient Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Biological Excipient Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Biological Excipient Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Biological Excipient Sales Market Share by Country/Region (2018-2023)
Table 31. Global Biological Excipient Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Biological Excipient Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Biological Excipient Sales by Country (2018-2023) & (K Units)
Table 34. Americas Biological Excipient Sales Market Share by Country (2018-2023)
Table 35. Americas Biological Excipient Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Biological Excipient Revenue Market Share by Country (2018-2023)
Table 37. Americas Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 38. Americas Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 39. APAC Biological Excipient Sales by Region (2018-2023) & (K Units)
Table 40. APAC Biological Excipient Sales Market Share by Region (2018-2023)
Table 41. APAC Biological Excipient Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Biological Excipient Revenue Market Share by Region (2018-2023)
Table 43. APAC Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 44. APAC Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 45. Europe Biological Excipient Sales by Country (2018-2023) & (K Units)
Table 46. Europe Biological Excipient Sales Market Share by Country (2018-2023)
Table 47. Europe Biological Excipient Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Biological Excipient Revenue Market Share by Country (2018-2023)
Table 49. Europe Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 50. Europe Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Biological Excipient Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Biological Excipient Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Biological Excipient Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Biological Excipient Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Biological Excipient Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Biological Excipient Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Biological Excipient
Table 58. Key Market Challenges & Risks of Biological Excipient
Table 59. Key Industry Trends of Biological Excipient
Table 60. Biological Excipient Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Biological Excipient Distributors List
Table 63. Biological Excipient Customer List
Table 64. Global Biological Excipient Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Biological Excipient Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Biological Excipient Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Biological Excipient Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Biological Excipient Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Biological Excipient Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Biological Excipient Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Biological Excipient Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Biological Excipient Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Biological Excipient Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Biological Excipient Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Biological Excipient Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Biological Excipient Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Biological Excipient Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ashland Inc. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 79. Ashland Inc. Biological Excipient Product Portfolios and Specifications
Table 80. Ashland Inc. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Ashland Inc. Main Business
Table 82. Ashland Inc. Latest Developments
Table 83. BASF Corporation Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 84. BASF Corporation Biological Excipient Product Portfolios and Specifications
Table 85. BASF Corporation Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BASF Corporation Main Business
Table 87. BASF Corporation Latest Developments
Table 88. Colorcon Inc. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 89. Colorcon Inc. Biological Excipient Product Portfolios and Specifications
Table 90. Colorcon Inc. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Colorcon Inc. Main Business
Table 92. Colorcon Inc. Latest Developments
Table 93. Evonik Industries Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 94. Evonik Industries Biological Excipient Product Portfolios and Specifications
Table 95. Evonik Industries Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Evonik Industries Main Business
Table 97. Evonik Industries Latest Developments
Table 98. FMC Corporation Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 99. FMC Corporation Biological Excipient Product Portfolios and Specifications
Table 100. FMC Corporation Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. FMC Corporation Main Business
Table 102. FMC Corporation Latest Developments
Table 103. Roquette Fr?res Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 104. Roquette Fr?res Biological Excipient Product Portfolios and Specifications
Table 105. Roquette Fr?res Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Roquette Fr?res Main Business
Table 107. Roquette Fr?res Latest Developments
Table 108. Signet Chemical Corporation Pvt. Ltd. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 109. Signet Chemical Corporation Pvt. Ltd. Biological Excipient Product Portfolios and Specifications
Table 110. Signet Chemical Corporation Pvt. Ltd. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Signet Chemical Corporation Pvt. Ltd. Main Business
Table 112. Signet Chemical Corporation Pvt. Ltd. Latest Developments
Table 113. The Archer Daniels Midland Company Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 114. The Archer Daniels Midland Company Biological Excipient Product Portfolios and Specifications
Table 115. The Archer Daniels Midland Company Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. The Archer Daniels Midland Company Main Business
Table 117. The Archer Daniels Midland Company Latest Developments
Table 118. The Dow Chemical Company Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 119. The Dow Chemical Company Biological Excipient Product Portfolios and Specifications
Table 120. The Dow Chemical Company Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. The Dow Chemical Company Main Business
Table 122. The Dow Chemical Company Latest Developments
Table 123. Wacker Chemie AG. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 124. Wacker Chemie AG. Biological Excipient Product Portfolios and Specifications
Table 125. Wacker Chemie AG. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Wacker Chemie AG. Main Business
Table 127. Wacker Chemie AG. Latest Developments
Table 128. Merck KGaA Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 129. Merck KGaA Biological Excipient Product Portfolios and Specifications
Table 130. Merck KGaA Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Merck KGaA Main Business
Table 132. Merck KGaA Latest Developments
Table 133. Colorcon Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 134. Colorcon Biological Excipient Product Portfolios and Specifications
Table 135. Colorcon Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Colorcon Main Business
Table 137. Colorcon Latest Developments
Table 138. Associated British Foods plc Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 139. Associated British Foods plc Biological Excipient Product Portfolios and Specifications
Table 140. Associated British Foods plc Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Associated British Foods plc Main Business
Table 142. Associated British Foods plc Latest Developments
Table 143. Signet Excipients Pvt. Ltd (IMCD) Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 144. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolios and Specifications
Table 145. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Signet Excipients Pvt. Ltd (IMCD) Main Business
Table 147. Signet Excipients Pvt. Ltd (IMCD) Latest Developments
Table 148. Sigachi Industries Limited Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 149. Sigachi Industries Limited Biological Excipient Product Portfolios and Specifications
Table 150. Sigachi Industries Limited Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Sigachi Industries Limited Main Business
Table 152. Sigachi Industries Limited Latest Developments
Table 153. Spectrum Chemical Manufacturing Corp. Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 154. Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolios and Specifications
Table 155. Spectrum Chemical Manufacturing Corp. Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Spectrum Chemical Manufacturing Corp. Main Business
Table 157. Spectrum Chemical Manufacturing Corp. Latest Developments
Table 158. IMCD Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 159. IMCD Biological Excipient Product Portfolios and Specifications
Table 160. IMCD Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. IMCD Main Business
Table 162. IMCD Latest Developments
Table 163. Clariant Basic Information, Biological Excipient Manufacturing Base, Sales Area and Its Competitors
Table 164. Clariant Biological Excipient Product Portfolios and Specifications
Table 165. Clariant Biological Excipient Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Clariant Main Business
Table 167. Clariant Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biological Excipient
Figure 2. Biological Excipient Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Excipient Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biological Excipient Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biological Excipient Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Topical
Figure 11. Global Biological Excipient Sales Market Share by Type in 2022
Figure 12. Global Biological Excipient Revenue Market Share by Type (2018-2023)
Figure 13. Biological Excipient Consumed in Hospitals
Figure 14. Global Biological Excipient Market: Hospitals (2018-2023) & (K Units)
Figure 15. Biological Excipient Consumed in Clinics
Figure 16. Global Biological Excipient Market: Clinics (2018-2023) & (K Units)
Figure 17. Biological Excipient Consumed in Others
Figure 18. Global Biological Excipient Market: Others (2018-2023) & (K Units)
Figure 19. Global Biological Excipient Sales Market Share by Application (2022)
Figure 20. Global Biological Excipient Revenue Market Share by Application in 2022
Figure 21. Biological Excipient Sales Market by Company in 2022 (K Units)
Figure 22. Global Biological Excipient Sales Market Share by Company in 2022
Figure 23. Biological Excipient Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Biological Excipient Revenue Market Share by Company in 2022
Figure 25. Global Biological Excipient Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Biological Excipient Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Biological Excipient Sales 2018-2023 (K Units)
Figure 28. Americas Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 29. APAC Biological Excipient Sales 2018-2023 (K Units)
Figure 30. APAC Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 31. Europe Biological Excipient Sales 2018-2023 (K Units)
Figure 32. Europe Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Biological Excipient Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 35. Americas Biological Excipient Sales Market Share by Country in 2022
Figure 36. Americas Biological Excipient Revenue Market Share by Country in 2022
Figure 37. Americas Biological Excipient Sales Market Share by Type (2018-2023)
Figure 38. Americas Biological Excipient Sales Market Share by Application (2018-2023)
Figure 39. United States Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Biological Excipient Sales Market Share by Region in 2022
Figure 44. APAC Biological Excipient Revenue Market Share by Regions in 2022
Figure 45. APAC Biological Excipient Sales Market Share by Type (2018-2023)
Figure 46. APAC Biological Excipient Sales Market Share by Application (2018-2023)
Figure 47. China Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Biological Excipient Sales Market Share by Country in 2022
Figure 55. Europe Biological Excipient Revenue Market Share by Country in 2022
Figure 56. Europe Biological Excipient Sales Market Share by Type (2018-2023)
Figure 57. Europe Biological Excipient Sales Market Share by Application (2018-2023)
Figure 58. Germany Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Biological Excipient Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Biological Excipient Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Biological Excipient Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Biological Excipient Sales Market Share by Application (2018-2023)
Figure 67. Egypt Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Biological Excipient in 2022
Figure 73. Manufacturing Process Analysis of Biological Excipient
Figure 74. Industry Chain Structure of Biological Excipient
Figure 75. Channels of Distribution
Figure 76. Global Biological Excipient Sales Market Forecast by Region (2024-2029)
Figure 77. Global Biological Excipient Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Biological Excipient Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Biological Excipient Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Biological Excipient Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Biological Excipient Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Biological Excipient
Figure 2. Biological Excipient Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Excipient Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biological Excipient Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biological Excipient Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Topical
Figure 11. Global Biological Excipient Sales Market Share by Type in 2022
Figure 12. Global Biological Excipient Revenue Market Share by Type (2018-2023)
Figure 13. Biological Excipient Consumed in Hospitals
Figure 14. Global Biological Excipient Market: Hospitals (2018-2023) & (K Units)
Figure 15. Biological Excipient Consumed in Clinics
Figure 16. Global Biological Excipient Market: Clinics (2018-2023) & (K Units)
Figure 17. Biological Excipient Consumed in Others
Figure 18. Global Biological Excipient Market: Others (2018-2023) & (K Units)
Figure 19. Global Biological Excipient Sales Market Share by Application (2022)
Figure 20. Global Biological Excipient Revenue Market Share by Application in 2022
Figure 21. Biological Excipient Sales Market by Company in 2022 (K Units)
Figure 22. Global Biological Excipient Sales Market Share by Company in 2022
Figure 23. Biological Excipient Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Biological Excipient Revenue Market Share by Company in 2022
Figure 25. Global Biological Excipient Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Biological Excipient Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Biological Excipient Sales 2018-2023 (K Units)
Figure 28. Americas Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 29. APAC Biological Excipient Sales 2018-2023 (K Units)
Figure 30. APAC Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 31. Europe Biological Excipient Sales 2018-2023 (K Units)
Figure 32. Europe Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Biological Excipient Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Biological Excipient Revenue 2018-2023 ($ Millions)
Figure 35. Americas Biological Excipient Sales Market Share by Country in 2022
Figure 36. Americas Biological Excipient Revenue Market Share by Country in 2022
Figure 37. Americas Biological Excipient Sales Market Share by Type (2018-2023)
Figure 38. Americas Biological Excipient Sales Market Share by Application (2018-2023)
Figure 39. United States Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Biological Excipient Sales Market Share by Region in 2022
Figure 44. APAC Biological Excipient Revenue Market Share by Regions in 2022
Figure 45. APAC Biological Excipient Sales Market Share by Type (2018-2023)
Figure 46. APAC Biological Excipient Sales Market Share by Application (2018-2023)
Figure 47. China Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Biological Excipient Sales Market Share by Country in 2022
Figure 55. Europe Biological Excipient Revenue Market Share by Country in 2022
Figure 56. Europe Biological Excipient Sales Market Share by Type (2018-2023)
Figure 57. Europe Biological Excipient Sales Market Share by Application (2018-2023)
Figure 58. Germany Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Biological Excipient Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Biological Excipient Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Biological Excipient Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Biological Excipient Sales Market Share by Application (2018-2023)
Figure 67. Egypt Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Biological Excipient Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Biological Excipient in 2022
Figure 73. Manufacturing Process Analysis of Biological Excipient
Figure 74. Industry Chain Structure of Biological Excipient
Figure 75. Channels of Distribution
Figure 76. Global Biological Excipient Sales Market Forecast by Region (2024-2029)
Figure 77. Global Biological Excipient Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Biological Excipient Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Biological Excipient Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Biological Excipient Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Biological Excipient Revenue Market Share Forecast by Application (2024-2029)
